Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in finland, 1997-2008: The huuti study

Journal of Addictive Diseases

Volumn 31, Issue 4, 2012, Pages 350-362

  Onyeka, Ifeoma N ^a   Uosukainen, Hanna ^a   Korhonen, Maarit Jaana ^a,b   Beynon, Caryl ^c   Bell, J Simon ^a,d   Ronkainen, Kimmo ^a   Föhr, Jaana ^e   Tiihonen, Jari ^a,f,g   Kauhanen, Jussi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e Helsinki Deaconess Institute   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

drug abuse pattern; drug use epidemiology; Finland; HUUTI consortium; substance use disorders

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; ILLICIT DRUG; OPIATE; PRESCRIPTION DRUG;

ABSTINENCE; ABUSE; ADDICTION SEVERITY INDEX; ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; DISEASE TRANSMISSION; DRUG ABUSE; DRUG ABUSE PATTERN; DRUG DEPENDENCE TREATMENT; DRUG USE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FINLAND; HELP SEEKING BEHAVIOR; HUMAN; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PREVALENCE; SUBSTANCE ABUSE; UNEMPLOYMENT; VOCATIONAL EDUCATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGIC METHODS; FEMALE; FINLAND; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84871968001     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2012.735563     Document Type: Article

References (40)

1. World Health Organization. 2011. Management of substance abuse: other psychoactive sub stances. http://www.who.int/substance-abuse/facts/ psychoactives/en/index.html (accessed October 30)
2. European Monitoring Centre for Drugs and Drug Addiction. Country overview: Finland. http://www.emcdda.europa.eu/publications/country-overviews/fi (accessed March 20, 2011)
3. Forsell, M, Virtanen, A, Jääskelainen, M, Alho, H, and, Partanen, A. Drug situation in Finland 2010: drug-related treatment. http://www.thl.fi/thl-client/pdfs/7445c896-5bc1-4bbc-b9e3-f41be4fa94e5 (accessed October 20, 2011)
4. Marsden, J. 2004. Long-term outcome of treatment for drug dependence. Psychiatry, 3: 47-9.
5. Saarnio, P. 2002. Factors associated with dropping out from outpatient treatment of alcohol-other drug abuse. Alcohol Treat Quar, 20: 17-33.
6. Saarnio, P, and, Knuuttila, V. 2003. A study of risk factors in dropping out from inpatient treatment of substance abuse. J Subst Use, 8: 33-8.
7. Sayre, S L, Schmitz, J M, Stotts, A L, Averill, P M, Rhoades, H M, and, Grabowski, J J. 2002. Determining predictors of attrition in an outpatient substance abuse program. Am J Drug Alcohol Abuse, 28: 55-72.
8. Manu, P, Burleson, J, and, Kranzler, H. 1994. Patient predictors of irregular discharge from inpatient substance abuse treatment. Am J Public Health, 84: 215-21.
9. Veach LJ, Remley TP, Kippers SM, Sorg JD. Retention predictors related to intensive outpatient programs for substance use disorders. Am J Drug Alcohol Abuse 2000; 26:417-28.
10. Webster, P, Mattick, R P, and, Baillie, A J. 1992. Characteristics of clients receiving treatment in Australian drug and alcohol agencies: a national census. Drug Alcohol Rev, 11: 111-19.
11. Hasan, N M, Loza, N, El-Dosoky, A. 2009. Characteristics of clients with substance abuse disorders in a private hospital in Cairo, Egypt. J Muslim Ment Health, 4: 9-15.
12. McLellan, A T, Kushner, H, Metzger, D. 1992. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat, 9: 199-213.
13. Blacken, P, Hendriks, V, Pozzi, G. 2010. European addiction severity index EuropASI manual. http://www.emcdda.europa.eu/html.cfm/index3647EN.html (accessed December 6)
14. Kokkevi, A, Richardson, C, Palermou, B, and, Leventakou, V. 1997. Reliability of drug dependents self-reports. Drug Alcohol Depend, 45: 55-61.
15. Stauffacher, M, and, Kokkevi, A. 1999. The Pompidou group treatment demand protocol: the first pan-European standard in the field. Eur Addict Res, 5: 191-6.
16. Simon, R, Donmall, M, Hartnoll, R. 1999. The EMCDDA/Pompidou group treatment indicator protocol: a European core item set for treatment monitoring and reporting. Eur Addict Res, 5: 197-207.
17. 2010. United Nations Office on Drugs and Crime. World drug report. http://www.unodc.org/documents/wdr/WDR-2010/World-Drug-Report-2010-lo-res.pdf (accessed December 10, 2010)
18. Gillespie, N A, Neale, M C, and, Kendler, K S. 2009. Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation, and progression to abuse. Addiction, 104: 430-8.
19. Freisthler, B, Gruenewald, P J, Johnson, F W, Treno, A J, and, Lascala, E A. 2005. An exploratory study examining the spatial dynamics of illicit drug availability and rates of drug use. J Drug Educ, 35: 15-27.
20. Degenhardt, L, Dierker, L, Chiu, W T. 2010. Evaluating the drug use "gateway" theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend, 108 (1-2): 84-97.
21. Kedia, S, Sell, M A, and, Relyea, G. 2007. Mono-versus polydrug abuse patterns among publicly funded clients. Subst Abuse Treat Prev Policy, 2: 33
22. Boys, A, Marsden, J, and, Strang, J. 2001. Understanding reasons for drug use amongst young people: a functional perspective. Health Edu Res, 16 (4): 457-69.
23. Gossop, M, Stewart, D, Treacy, S, and, Marsden, J. 2002. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction, 97: 39-47.
24. Warner-Smith, M, Darke, S, Lynskey, M, and, Hall, W. 2001. Heroin overdose: causes and consequences. Addiction, 96: 1113-25.
25. Trisler, Z, Seme, K, Poljak, M, Celan-Lucu, B, and, Sakoman, S. 1999. Prevalence of hepatitis c and g virus infections among intravenous drug users in Slovenia and Croatia. Scand J Infect Dis, 31: 33-5.
26. Mathers, B M, Degenhardt, L, Phillips, B. 2008. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet, 372: 1733-45.
27. Loebstein, R, Mahagna, R, Maor, Y. 2011. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Israel Med Assoc J, 10 (11): 775-8.
28. Li J, Liu H, Luo J, Koram N, Detels R. Sexual transmissibility of HIV among opiate users with concurrent sexual partnerships: an egocentric network study in Yunnan, China. Addiction 2011; 106:1780-7.
29. Brodish, P, Singh, K, Rinyuri, A. 2011. Evidenc of high-risk sexual behaviors among injection drug users in Kenya PLACE study. Drug Alcohol Depend, 119: 138-41.
30. Novelli, L A, Sherman, S G, Havens, J R, Strathdee, S A, and, Sapun, M. 2004. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend, 77: 303-9.
31. Miller, C L, Strathdee, S A, Kerr, T, Li, K, and, Wood, E. 2006. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health, 38: 462-4.
32. Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health 2006; 38: 462-4.
33. Beynon, C, Bellis, M A, Millar, T, Meier, P, Thomson, R, and, Mackway, J K. 2001. Hidden need for drug treatment services: measuring levels of problematic drug use in the North West of England. J Public Health Med, 23 (4): 286-91.
34. Jessup, M A, Humphreys, J C, Brindis, C D, and, Lee, K A. 2003. Extrinsic barriers to substance abuse treatment among pregnant drug dependent women. J Drug Issues, 33: 285-304.
35. Foltran, F, Gregori, D, Franchin, L, Verduci, E, and, Giovannini, M. 2011. Effect of alcohol consumption in prenatal life, childhood, and adolescence on child development. Nutr Rev, 69 (11): 642-59.
36. Ellickson, P L, Tucker, J, and, Klein, D J. 2003. Ten-year prospective study of public health problems associated with early drinking. Pediatrics, 111: 949-55.
37. National Institute on Drug Abuse. Preventing drug use among children. http://drugabuse.gov/pdf/prevention/redbook.pdf (accessed December 13, 2010)
38. yle: UUTISET. Prescription drug abuse rife. http://yle.fi/uutiset/ prescription-drug-abuse-rife-1990833. (accessed August 31, 2011)
39. Moller-Leimkuhler, A M. 2002. Barriers to help-seeking by men: a review of sociocultural and clinical literature with particular reference to depression. J Affect Disord, 71 (1-3): 1-9.
40. European Monitoring Centre for Drugs and Drug Addiction. 2007. Methods and definitions: problematic drug use population. http://www.emcdda.europa.eu/ stats07/PDU/methods (accessed December 13, 2010)